• Eugene Fry has been named chief compliance officer for SecureCARE Technologies (Austin, Texas), a provider of Internet-based document exchange and e-signature solutions for the healthcare industry. In addition to his role as chief compliance officer, Fry is vice president of product and technology development. He is the company's patent custodian and handles SecureCARE's ongoing competition assessment.

• Michael Khavinson has been named president of Stelex (Bensalem, Pennsylvania), a subsidiary of Vital Signs (Totowa, New Jersey). Khavinson, a founding partner of Stelex, most recently served as executive vice president of global marketing and strategic planning for Vital Signs. Stelex is a provider of enterprise-wide compliance services and solutions to regulated industries. Vital Signs and its subsidiaries manufacture primarily single-use medical products for the anesthesia, respiratory/critical care and sleep/ventilation markets.

• Thoratec (Pleasanton, California) has reported several changes within the management team of its Cardiovascular Division, which includes all of the company's ventricular assist device and vascular graft product lines. Steven Brandt has been named vice president, sales and marketing. Brandt has more than two decades of sales and marketing experience with medical device companies, including St. Jude Medical and Medtronic. Laxmi Peri has joined the company as vice president, technology and product development, coming from St. Jude Medical, where he spent 10 years in senior research and product development positions. David Farrar, PhD, has been named to the new position of vice president of research and scientific affairs. Farrar joined Thoratec in 1980 and was most recently vice president, research and development. Debbie Schultz has joined the company as senior director of customer driven quality. She was vice president, customer support, for nuclear medicine at ADAC Laboratories/Philips Medical Systems.

• Brian Andrew will become general counsel of eye care services provider TLC Vision (St. Louis), effective Feb. 1. Most recently, Andrew was the chair of the Health Law Practice Group and a member in the St. Louis office of Husch & Eppenberger. Andrew replaces Robert May, who retired at the end of last year.

• Frederick Robertson, MD, has joined TomoTherapy (Madison, Wisconsin) as CEO. Robertson spent almost nine years with Marquette Medical Systems, most recently as CEO and president, prior to its acquisition by GE Medical. Prior to joining the company, Robertson was with the Medical College of Wisconsin both as a pediatric anesthesiologist and assistant professor of anesthesiology. TomoTherapy has developed a medical system that combines onboard computed tomography imaging with conformal radiation therapy for cancer patients.

• Shelli Field has been named president of the TVG Marketing Research & Consulting business unit of PDI (Saddle River, New Jersey). Field joined TVG in 2002 as an executive vice president and member of the company's guiding executive committee. PDI is a provider of sales and marketing services to the medical device, diagnostics and biopharmaceutical industries.